Sandler Laura Lee sold ORKA
May 1, 2026 · Form 4 insider transaction
Sandler Laura Lee sold 100 shares of Oruka Therapeutics, Inc. at $68.48 per share, a transaction worth $6.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$68.48
Total value
$6.8K
InsiderSandler Laura Lee
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 1, 2026
Filing dateMay 1, 2026
Shares owned after236,984
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.